Europe Market for Mechanical Thrombectomy 2017 - MedCore is a new market research publication announced by Reportstack.
General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
There will be significant market growth in the mechanical thrombectomy market over the forecast period, driven by growth in unit sales as mechanical thrombectomy is adopted as standard of care for acute ischemic stroke patients.
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
There will be significant market growth in the mechanical thrombectomy market over the forecast period, driven by growth in unit sales as mechanical thrombectomy is adopted as standard of care for acute ischemic stroke patients.
Complete report available @ Europe Market for Mechanical Thrombectomy 2017 - MedCore
This market includes stent retrievers and suction thrombectomy catheters. The majority of the time a combination of the two categories is used but there a number of factors that can impact treatment decisions, one key factor being physician preference. Studies found new stent retriever devices are superior to first generation aspiration devices but there have been fewer studies comparing the second generation of both categories.
There had been a strong evolution in Europe towards combination of aspiration and stent retriever but now the market is moving even farther towards aspiration only techniques. Both categories of devices have are required in specific cases as certain devices appear to more successful based on the anatomy, clot morphology and clot locations. There has been huge variability on reported success rates with aspiration-only which influences the frequency that a stent retriever is required in combination. Additional clinical trials will influence whether the devices continue to be used in conjunction or whether one category will cannibalize shares form the other.
The ASP of both categories of devices is expected to remain stable over the forecast period. The stent retriever drives the market value higher quicker due to the higher ASP it commands and the need for more than one device per procedure.
Scope
2013-2023
2013-2023
Companies Mentioned
Medtronic Stryker Codman & Shurtleff, Inc. St. Jude Medical Nevro Carl Zeiss Boston Scientific LivaNova Terumo MicroVention Penumbra Inc. Leica Integra LifeSciences BrainLab Balt Magstim Phenox MagVenture Elekta Moëller Wedel Misonix Sophysa Aesculap MAG & More Neurosoft Acandis Soring Brainsway Nexstim Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment